Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: Are β-lactamase inhibitors of therapeutic value?

Clinical Infectious Diseases

Volumn 27, Issue 1, 1998, Pages 76-83

  Piroth, Lionel ^a   Aubé, Hervé ^a,b   Doise, Jean Marc ^a   Vincent Martin, Michel ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; BETA LACTAMASE INHIBITOR; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; PENICILLIN DERIVATIVE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM; TICARCILLIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CATHETERIZATION; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; FEMALE; GRAM NEGATIVE INFECTION; HAND WASHING; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS CATHETER; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; RESUSCITATION; RISK FACTOR; TREATMENT OUTCOME;

EID: 0031874727     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514643     Document Type: Article

References (20)

1. Jacoby GA, Medeiros AA. More extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991;35:1697-704.
2. Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996;174:529-36.
3. Lucet JC, Chevret S, Vanjak D, et al. Risk factors for acquiring extended-spectrum beta-lactamases Enterobacteriaceae (ESBLE) in ICU [abstract no 637]. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washington, DC: American Society for Microbiology, 1992:217.
4. De Champs C, Rouby D, Guelon D, et al. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-I (TEM-3) beta-lactamase. J Hosp Infect 1991;18:5-13.
5. Arlet G, Sanson Le Pors MJ, Rouveau M, et al. Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase. Eur J Clin Microbiol Infect Dis 1990;9:797-803.
6. Pena C, Pujol M, Ricart A, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended-spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 1997;35:9-16.
7. De Champs C, Sauvant MP, Chanal C, Sirot D, Gazuy N, Malhuret R. Prospective survey of colonisation and infection caused by expanded-spectrum-β-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. J Clin Microbiol 1989;27:2887-90.
8. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353-8.
9. Philippon A, Ben Redjeb S, Foumier G, Ben Hassen A. Epidemiology of extended-spectrum β-lactamases. Infection 1989;17:347-54.
10. Brun-Buisson C, Legrand P, Philippon A, Legrand P, Montravers F, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987;2:302-6.
11. Sirot J, Chanal C, Petit A, Sirot D, Labia R, Gerbaud G. Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated β-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Rev Infect Dis 1988;10:850-9.
12. Naumovski L, Quinn JP, Miyashiro D, et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992;36:1991-6.
13. Quinn JP. Clinical significance of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1994;13(suppl 1):S39-42.
14. Rice LB, Eckstein EC, De Vente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996;23:118-24.
15. Venezia RA, Scarano FJ, Preston KE, et al. Molecular epidemiology of an SHV-5 extended-spectrum β-lactamase in Enterobacteriaceae isolated from infants in an neonatal intensive care unit. Clin Infect Dis 1995;21:915-23.
16. Hibberd PL, Jacoby GA. Multiple drug resistant Klebsiella pneumoniae (MDRKP) strains: predictors of acquisition and mortality [abstract no C46]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, FL). Washington, DC: American Society for Microbiology, 1994:87.
17. Freeman J, Mc Gowan JE. Risk factors for nosocomial infection. J Infect Dis 1978;138:811-9.
18. Maki DG. Risk factors for nosocomial infection in intensive care. Arch Intern Med 1989;149:30-3.
19. French GL, Cheng AFB, Wong SL, Donnan S. Repeated prevalence surveys for monitoring effectiveness of hospital infection control. Lancet 1989;2:1021-3.
20. Acar J, Bergogne-Berezin E, Chabbert Y, et al. Communiqué 1992 du Comité de l'Antibiogramme de la société Française de Microbiologie. Pathol Biol (Paris) 1992;40:741-8.